Filter News
Area of Research
- (-) Isotopes (7)
- (-) Materials (21)
- (-) Neutron Science (8)
- Advanced Manufacturing (1)
- Biology and Environment (14)
- Clean Energy (14)
- Computational Engineering (1)
- Computer Science (1)
- Fusion and Fission (2)
- Isotope Development and Production (1)
- Materials for Computing (4)
- National Security (13)
- Nuclear Science and Technology (3)
- Quantum information Science (1)
- Sensors and Controls (1)
- Supercomputing (27)
News Topics
- (-) Biomedical (8)
- (-) Cybersecurity (4)
- (-) High-Performance Computing (3)
- (-) Isotopes (10)
- (-) Microscopy (12)
- (-) Security (2)
- (-) Space Exploration (1)
- 3-D Printing/Advanced Manufacturing (15)
- Advanced Reactors (1)
- Artificial Intelligence (4)
- Big Data (1)
- Bioenergy (9)
- Biology (8)
- Biotechnology (1)
- Buildings (2)
- Chemical Sciences (20)
- Climate Change (5)
- Composites (3)
- Computer Science (11)
- Coronavirus (7)
- Critical Materials (8)
- Decarbonization (5)
- Energy Storage (20)
- Environment (10)
- Exascale Computing (1)
- Frontier (3)
- Fusion (3)
- Grid (2)
- ITER (1)
- Machine Learning (2)
- Materials (40)
- Materials Science (39)
- Molten Salt (2)
- Nanotechnology (22)
- National Security (3)
- Net Zero (1)
- Neutron Science (42)
- Nuclear Energy (4)
- Partnerships (8)
- Physics (16)
- Polymers (6)
- Quantum Computing (1)
- Quantum Science (11)
- Renewable Energy (1)
- Summit (4)
- Sustainable Energy (8)
- Transformational Challenge Reactor (1)
- Transportation (6)
Media Contacts
![An artist's rendering of the Ultium Cells battery cell production facility to be built in Spring Hill, Tennessee, which will employ 1,300 people. Recognizing the unique expertise of their organizations, ORNL, TVA, and the Tennessee Department of Economic and Community Development have been working together for several years to bring startups developing battery technologies for EVs and established automotive firms to Tennessee. Credit: Ultium Cells](/sites/default/files/styles/list_page_thumbnail/public/2022-02/UltiumCellsLLC-SpringHill-TN-Rendering_0.jpg?h=f9f6f138&itok=_TJq1Ajl)
ORNL, TVA and TNECD were recognized by the Federal Laboratory Consortium for their impactful partnership that resulted in a record $2.3 billion investment by Ultium Cells, a General Motors and LG Energy Solution joint venture, to build a battery cell manufacturing plant in Spring Hill, Tennessee.
![Mars Rover 2020](/sites/default/files/styles/list_page_thumbnail/public/2019-03/Mars_0.jpg?h=c44fcfa1&itok=gSstQOJO)
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
![Three ORNL scientists have been elected fellows of the American Association for the Advancement of Science, or AAAS, the world’s largest general scientific society and publisher of the Science family of journals. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2022-01/AAAS_fellows_resize_0.jpg?h=e91a75a9&itok=y20mbH61)
Three ORNL scientists have been elected fellows of the American Association for the Advancement of Science, or AAAS, the world’s largest general scientific society and publisher of the Science family of journals.
![Miaofang Chi, a scientist in the Center for Nanophase Materials Sciences, received the 2021 Director’s Award for Outstanding Individual Accomplishment in Science and Technology. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-12/2021-P09692_0.jpg?h=9bbd619b&itok=4iANdQKl)
A world-leading researcher in solid electrolytes and sophisticated electron microscopy methods received Oak Ridge National Laboratory’s top science honor today for her work in developing new materials for batteries. The announcement was made during a livestreamed Director’s Awards event hosted by ORNL Director Thomas Zacharia.
![Ashleigh Kimberlin and Mikayla Molnar achieve success with a gas-trapping apparatus for Ac-225 production. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-11/Acgastrapping-1.png?h=71976bb4&itok=TbfsnNxp)
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.
![Ten scientists from the Department of Energy’s Oak Ridge National Laboratory are among the world’s most highly cited researchers. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-11/2008-P01679_0.jpg?h=6acbff97&itok=ewBiiftq)
Ten scientists from the Department of Energy’s Oak Ridge National Laboratory are among the world’s most highly cited researchers, according to a bibliometric analysis conducted by the scientific publication analytics firm Clarivate.
![Larry Baylor, left, and Andrew Lupini have been elected fellows of the American Physical Society. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-10/APSfellows.jpg?h=e91a75a9&itok=rDVqiCkQ)
ORNL's Larry Baylor and Andrew Lupini have been elected fellows of the American Physical Society.
![Sergei Kalinin](/sites/default/files/styles/list_page_thumbnail/public/2021-05/2019-P00127%20%281%29.jpg?h=49ab6177&itok=anhrhQ-g)
Sergei Kalinin, a scientist and inventor at the Department of Energy’s Oak Ridge National Laboratory, has been elected a fellow of the Microscopy Society of America professional society.
![Targeted alpha therapy can deliver radiation to specific cells, with minimal effect on surrounding, healthy cells. Credit: Michelle Lehman and Jaimee Janiga/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/gif_high_res.gif?h=ae1281eb&itok=QtNBjm3O)
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
![Neutron scattering experiments show electric charges, shown in red, blue and grey, in the SARS-CoV-2 main protease site where telaprevir binds to the structure. The experiments provide critical data for the design of small-molecule drugs to treat COVID-19. Credit: Jill Hemman and Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/after_transprent_background-wFill.png?h=c71d0c67&itok=jGFt_Ggj)
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.